Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02528500 · ClinicalTrials.gov registry record · NA
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms
A NA study, sponsored by W.L.Gore & Associates.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02528500 is a NA study that has completed, run by W.L.Gore & Associates. The registered enrollment target is 10 participants.
The verdict
NCT02528500, a NA study, has completed, sponsored by W.L.Gore & Associates.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study will assess the initial feasibility of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) in the treatment of Aortic Aneurysms Involving the Visceral Branch Vessels.
Interventions
- DEVICE GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-11 |
| Est. Completion | 2023-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02528500
The ClinicalTrials.gov registry entry for NCT02528500 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis is the first listed.
NCT02528500 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02528500 about?
NCT02528500 is a clinical study titled "GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms". This study will assess the initial feasibility of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) in the treatment of Aortic Aneurysms Involving the Visceral Branch Vessels.
What is the current status of trial NCT02528500?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2015-11. Estimated completion is 2023-02.
What interventions are being tested in trial NCT02528500?
The interventions under investigation include: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (DEVICE).
Who is sponsoring clinical trial NCT02528500?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.